Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"RN7SL737P" is a processed pseudogene in the human genome derived from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP)[1][3][5][7][9]. While the authentic 7SL RNA is an essential non-coding RNA involved in the targeting of secretory proteins to the endoplasmic reticulum via the SRP complex, pseudogenes like RN7SL737P result from the reverse transcription and integration of RNA sequences back into the genome. Such pseudogenes are typically truncated, lack regulatory elements, and are not transcribed or translated into functional products in normal physiology[3][5][7]. The majority of 7SL RNA-like sequences in the human genome are nonfunctional pseudogenes, and no evidence supports any direct biological function, disease involvement, or role as a drug target for RN7SL737P[1][3][5][7].\nThe gene is a non-coding, non-functional sequence, not a therapeutic target, not involved in significant biological or disease processes, and not relevant for drug interaction or biomarker development.\nAny reference to "RN7SL737P" as a target is likely incorrect, as it is not a gene encoding a functional product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 7SL RNA cytoplasmic 737 pseudogene (RN7SL737P).